TMH (The Medical House) sells non-core SQ-PEN needle-free insulin
This article was originally published in Clinica
UK medical technology company The Medical House (TMH) has sold its SQ-PEN needle-free insulin injector business to Dutch company Diabetes Management International (DMI) for up to £810,000 ($1.6m), which includes £60,000 for inventory held by TMH.
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.